News
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...
The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results